A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Pfizer
Pfizer
Ikena Oncology
Eli Lilly and Company
National Cancer Institute (NCI)
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center